{"slideshow_credits": null, "snippet": "The justices ruled on Monday that brand-name drug makers could face antitrust charges for paying generic competitors to keep cheaper copies of a drug off the market.", "abstract": "Supreme Court rules in 5-to-3 vote that pharmaceutical companies can face antitrust charges by Federal Trade Commission for paying generic competitors to keep cheaper copies of a drug off the market; decision is likely to increase number of generic drugs in marketplace and benefit consumers.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Edward", "role": "reported", "lastname": "WYATT", "rank": 1, "organization": ""}], "original": "By EDWARD WYATT", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/06/18/business/supreme-court-says-drug-makers-can-be-sued-over-pay-for-delay-deals.html", "lead_paragraph": "The justices ruled on Monday that brand-name drug makers could face antitrust charges for paying generic competitors to keep cheaper copies of a drug off the market.", "headline": {"main": "Supreme Court Lets Regulators Sue Over Generic Drug Deals", "print_headline": "Justices Rule for the F.T.C. in a Generic Drug Case"}, "_id": "51bf2d917e0d9c0839d28f48", "word_count": "818", "multimedia": [{"height": 126, "url": "images/2013/06/18/business/Generic/Generic-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/06/18/business/Generic/Generic-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 733, "url": "images/2013/06/18/business/Generic/Generic-articleLarge.jpg", "legacy": {"xlarge": "images/2013/06/18/business/Generic/Generic-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "733"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/06/18/business/Generic/Generic-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/06/18/business/Generic/Generic-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-06-18T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Antitrust Laws and Competition Issues", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Generic Brands and Products", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Supreme Court", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "Suits and Litigation (Civil)", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Federal Trade Commission", "name": "organizations", "is_major": "Y", "rank": "6"}, {"value": "Actavis Group", "name": "organizations", "is_major": "N", "rank": "7"}, {"value": "Solvay Pharmaceuticals", "name": "organizations", "is_major": "N", "rank": "8"}], "blog": [], "subsection_name": null, "type_of_material": "News"}